Twinter--I was struck by your comment "I bet Mayo is going to do both our breast cancer and pancreatic study for a couple of reasons. And that most likely nobody or almost nobody here cares lol"
Most likely nobody here cares? That's a big diss on the board. Unwarranted and presumptuous, if you ask me. I really don't know where that is coming from, but it is both wrong and unnecessarily chippy.
I think you are reading the room wrong. I generally appreciate the information you dig up, but it's all AI, all the time, and the number of posts and the density can be overwhelming. And very little critique or a personal perspective that can provide big picture context. You clearly have good research skills... though heavily reliant on AI. Where's the human touch? And a little critique or perspective goes a long way.
Here's an example regarding the Pre-Spy/I- Spy/Man From Uncle point you mentioned, about the expansion from breast cancer studies into solid tumors. Sure, in the long-term, that's great. But a focus on breast cancer--where we have concrete clinical results in TNBC--might be much better for Cytodyn because a)--breast cancer is in our wheelhouse, and we are still in the PROVE IT phase of research, and b) moving forward in a single indication would move results along more quickly, in a shorter timeline, in a way that a "basket" approach will not. Perhaps you have plenty of time, but I'd like to see some meaningful increase in the share price sooner than later...
Look, you could just ask AI to critique itself and get something similar... But thinking things through and having a critical perspective in the moment is still plenty useful in this day and age. Insight and knowledge as an organic outcome that flows and builds upon observation and discourse into significance... Well, that is basically the epistemology of this message board, in a nutshell.
Read the room, share, add a little perspective, and explore/tease out the implications of your otherwise excellent research.
And then you whet our appetite with the comment about Mayo doing both the breast cancer and pancreatic study "for a couple of reasons." Without telling us what those reasons are!
So, please--Out with those reasons!
Most likely nobody here cares? That's a big diss on the board. Unwarranted and presumptuous, if you ask me. I really don't know where that is coming from, but it is both wrong and unnecessarily chippy.
I think you are reading the room wrong. I generally appreciate the information you dig up, but it's all AI, all the time, and the number of posts and the density can be overwhelming. And very little critique or a personal perspective that can provide big picture context. You clearly have good research skills... though heavily reliant on AI. Where's the human touch? And a little critique or perspective goes a long way.
Here's an example regarding the Pre-Spy/I- Spy/Man From Uncle point you mentioned, about the expansion from breast cancer studies into solid tumors. Sure, in the long-term, that's great. But a focus on breast cancer--where we have concrete clinical results in TNBC--might be much better for Cytodyn because a)--breast cancer is in our wheelhouse, and we are still in the PROVE IT phase of research, and b) moving forward in a single indication would move results along more quickly, in a shorter timeline, in a way that a "basket" approach will not. Perhaps you have plenty of time, but I'd like to see some meaningful increase in the share price sooner than later...
Look, you could just ask AI to critique itself and get something similar... But thinking things through and having a critical perspective in the moment is still plenty useful in this day and age. Insight and knowledge as an organic outcome that flows and builds upon observation and discourse into significance... Well, that is basically the epistemology of this message board, in a nutshell.
Read the room, share, add a little perspective, and explore/tease out the implications of your otherwise excellent research.
And then you whet our appetite with the comment about Mayo doing both the breast cancer and pancreatic study "for a couple of reasons." Without telling us what those reasons are!
So, please--Out with those reasons!
8
